$SHMP
NaturalShrimp Inc Stock $shmp

$shmp Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223005319 Filed on February 16, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue	$52.68K	$97.94K	$16.64K
YoY Change	207.53%	488.6%
Cost Of Revenue	$200.9K
YoY Change
Gross Profit	-$148.2K	$97.94K
YoY Change
Gross Profit Margin	-281.26%	100.0%
Selling, General & Admin	$1.754M	$2.356M	$1.926M
YoY Change	-96.18%	22.33%	250.78%
% of Gross Profit		2405.88%
Research & Development	$0.00	$14.21K	$20.36K
YoY Change	-100.0%	-30.19%
% of Gross Profit		14.51%
Depreciation & Amortization	$813.1K	$416.0K	$218.1K
YoY Change	-25.28%	90.71%	1100.32%
% of Gross Profit		424.74%
Operating Expenses	$2.521M	$3.154M	$2.532M
YoY Change	-94.63%	24.57%	346.36%
Operating Profit	-$2.669M	-$3.057M	-$2.516M
YoY Change		21.51%	343.43%
Interest Expense	-$1.315M	$15.86M	$80.99K
YoY Change	41.24%	19476.76%	90.38%
% of Operating Profit
Other Income/Expense, Net	$124.2K	$18.23M	-$30.85M
YoY Change		-159.1%	72420.61%
Pretax Income	-$4.435M	$15.18M	-$33.37M
YoY Change	-90.67%	-145.48%	5371.38%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$4.495M	$15.18M	-$33.37M
YoY Change	-90.54%	-145.48%	5381.03%
Net Earnings / Revenue	-8533.24%	15494.42%	-200520.1%
Basic Earnings Per Share		$0.02	-$0.05
Diluted Earnings Per Share	$0.00	$0.01	-$52.50K
COMMON SHARES
Basic Shares Outstanding	783.2M shares	751.4M shares	636.5M shares
Diluted Shares Outstanding		1.629B shares	635.5M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$216.5K	$141.9K	$2.665M
YoY Change	-87.52%	-94.68%	754.64%
Cash & Equivalents	$216.5K	$141.9K	$2.665M
Short-Term Investments
Other Short-Term Assets	$1.623M	$617.1K	$5.327M
YoY Change	-46.11%	-88.41%	584.62%
Inventory	$25.73K	$101.9K	$28.13K
Prepaid Expenses	$286.6K	$490.1K	$326.5K
Receivables	$17.33K	$7.502K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.882M	$868.4K	$8.020M
YoY Change	-61.02%	-89.17%	635.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.04M	$15.35M	$13.77M
YoY Change	1.66%	11.51%	-3.61%
Goodwill
YoY Change
Intangibles	$6.269M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.66M	$16.07M	$19.88M
YoY Change	-14.29%	-19.16%	96251.67%
Total Long-Term Assets	$30.70M	$31.42M	$33.64M
YoY Change	-7.15%	-6.61%	135.23%
TOTAL ASSETS
Total Short-Term Assets	$1.882M	$868.4K	$8.020M
Total Long-Term Assets	$30.70M	$31.42M	$33.64M
Total Assets	$32.59M	$32.29M	$41.66M
YoY Change	-14.02%	-22.5%	170.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.510M	$3.523M	$3.321M
YoY Change	25.24%	6.08%	270.51%
Accrued Expenses	$1.315M	$300.0K	$500.5K
YoY Change	533.97%	-40.06%	-42.34%
Deferred Revenue
YoY Change
Short-Term Debt	$760.2K	$765.2K	$515.5K
YoY Change	47.49%	48.46%	-71.73%
Long-Term Debt Due	$3.071M	$2.315M	$96.00K
YoY Change	3099.06%	2311.82%	-14.01%
Total Short-Term Liabilities	$11.22M	$9.060M	$24.35M
YoY Change	-48.63%	-62.8%	527.36%
LONG-TERM LIABILITIES
Long-Term Debt	$21.31M	$20.27M	$483.6K
YoY Change	675.41%	4091.61%	-91.12%
Other Long-Term Liabilities	$125.2K	$231.7K	$303.9K
YoY Change	-56.27%	-23.76%	10.36%
Total Long-Term Liabilities	$21.44M	$20.50M	$787.5K
YoY Change	606.4%	2503.41%	-86.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.22M	$9.060M	$24.35M
Total Long-Term Liabilities	$21.44M	$20.50M	$787.5K
Total Liabilities	$32.66M	$29.56M	$25.14M
YoY Change	31.27%	17.59%	164.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$167.5M	-$163.0M	-$101.8M
YoY Change	11.66%	60.16%
Common Stock	$80.38K	$76.89K	$64.18K
YoY Change	19.08%	19.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$45.69M	-$42.89M	$14.60M
YoY Change
Total Liabilities & Shareholders Equity	$32.59M	$32.29M	$41.66M
YoY Change	-14.02%	-22.5%	170.68%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$4.495M	$15.18M	-$33.37M
YoY Change	-90.54%	-145.48%	5381.03%
Depreciation, Depletion And Amortization	$813.1K	$416.0K	$218.1K
YoY Change	-25.28%	90.71%	1100.32%
Cash From Operating Activities	-$1.974M	-$254.3K	-$8.048M
YoY Change	427.48%	-96.84%	4849.02%
INVESTING ACTIVITIES
Capital Expenditures	$118.3K	$2.221M	-$606.0K
YoY Change	-122.19%	-466.56%	-89.11%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$700.0K	$0.00
YoY Change
Cash From Investing Activities	-$118.3K	-$1.521M	-$606.0K
YoY Change	-77.81%	151.05%	-89.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.167M	1.356M	10.52M
YoY Change	-9128.12%	-87.11%	83.83%
NET CHANGE
Cash From Operating Activities	-1.974M	-254.3K	-8.048M
Cash From Investing Activities	-118.3K	-1.521M	-606.0K
Cash From Financing Activities	2.167M	1.356M	10.52M
Net Change In Cash	74.60K	-419.6K	1.865M
YoY Change	-108.01%	-122.5%	-49692.29%
FREE CASH FLOW
Cash From Operating Activities	-$1.974M	-$254.3K	-$8.048M
Capital Expenditures	$118.3K	$2.221M	-$606.0K
Free Cash Flow	-$2.092M	-$2.476M	-$7.442M
YoY Change	-1417.89%	-66.73%	-237.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001465470
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit		usd
CY2022Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2022Q1	SHMP	Restructured August Note Payable RestructuredAugustNotePayable		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2022Q1	us-gaap	Senior Notes SeniorNotes		usd
CY2022Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2021Q4	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
CY2022Q4	SHMP	Financing Costs FinancingCosts		usd
	SHMP	Financing Costs FinancingCosts		usd
CY2021Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2021Q4	SHMP	Change In Fair Value Of Restructured Notes ChangeInFairValueOfRestructuredNotes		usd
	SHMP	Change In Fair Value Of Restructured Notes ChangeInFairValueOfRestructuredNotes		usd
CY2022Q4	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan		usd
CY2021Q4	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan		usd
	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan		usd
CY2022Q4	SHMP	Gain On Vero Blue Note Settlement GainOnVeroBlueNoteSettlement		usd
CY2021Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q4	us-gaap	Legal Fees LegalFees		usd
	us-gaap	Legal Fees LegalFees		usd
CY2021Q4	SHMP	Loss Due To Fire LossDueToFire		usd
	SHMP	Loss Due To Fire LossDueToFire		usd
CY2021Q4	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares		usd
CY2021Q4	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares		usd
	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares		usd
CY2022Q4	SHMP	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares		usd
CY2021Q4	SHMP	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares		usd
	SHMP	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares		usd
CY2021Q4	us-gaap	Dividends Dividends		usd
	us-gaap	Dividends Dividends		usd
CY2022Q2	SHMP	Common Stock Issued For Legal Settlement To Nsh Shareholders CommonStockIssuedForLegalSettlementToNshShareholders		usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature		usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q3	SHMP	Common Stock Issued For Legal Settlement To Nsh Shareholders CommonStockIssuedForLegalSettlementToNshShareholders		usd
CY2022Q3	SHMP	Common Stock Issued From Shares Payable CommonStockIssuedFromSharesPayable		usd
CY2021Q2	SHMP	Conversion Of Series B Ps To Common Stock Amount ConversionOfSeriesBPsToCommonStockAmount		usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2021Q4	SHMP	Common Shares To Be Issued For Technical And Equipment Rights Agreement CommonSharesToBeIssuedForTechnicalAndEquipmentRightsAgreement		usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
	SHMP	Change In Fair Value Of Promissory Notes ChangeInFairValueOfPromissoryNotes		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	SHMP	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt		usd
	SHMP	Loss Due To Fire LossDueToFire		usd
	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan		usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts		usd
	SHMP	Increase Decrease In Accrued Expenses Related Parties IncreaseDecreaseInAccruedExpensesRelatedParties		usd
	SHMP	Cash Received For Fire Damage To Fixed Assets CashReceivedForFireDamageToFixedAssets		usd
	SHMP	Cash Paid For Patent Acquisition CashPaidForPatentAcquisition		usd
	SHMP	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci		usd
	SHMP	Cash Paid For License Agreement CashPaidForLicenseAgreement		usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess		usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
	SHMP	Repayments Of Notes Payable Related Party RepaymentsOfNotesPayableRelatedParty		usd
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	SHMP	Proceeds From Promissory Note Related Parties ProceedsFromPromissoryNoteRelatedParties		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	SHMP	Proceeds From Convertible Debentures Receipt ProceedsFromConvertibleDebenturesReceipt		usd
	SHMP	Payments On Convertible Debentures PaymentsOnConvertibleDebentures		usd
	SHMP	Payments On Notes Payable PaymentsOnNotesPayable		usd
	SHMP	Proceeds From Sale Of Series E Ps ProceedsFromSaleOfSeriesEPs		usd
	SHMP	Redemption Of Series D Ps RedemptionOfSeriesDPs		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	SHMP	Construction In Process Transferred To Fixed Assets ConstructionInProcessTransferredToFixedAssets		usd
	SHMP	Shares Issued Upon Conversion Of Convertible Debentures SharesIssuedUponConversionOfConvertibleDebentures		usd
	SHMP	Shares Issued Upon Conversion Of Preferred Stock SharesIssuedUponConversionOfPreferredStock		usd
	SHMP	Cancellation Of Right Of Use Asset And Lease Liability CancellationOfRightOfUseAssetAndLeaseLiability		usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1		shares
	SHMP	Shares Issued As Consideration For Patent Acquisition SharesIssuedAsConsiderationForPatentAcquisition		usd
	SHMP	Shares Issued As Consideration For Acquisition Of Remaining Nci SharesIssuedAsConsiderationForAcquisitionOfRemainingNci		usd
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2022	SHMP	Gain On Extinguishment Of Note GainOnExtinguishmentOfNote		usd
	SHMP	Additions To Derivative Liabilities AdditionsToDerivativeLiabilities		usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
	SHMP	Additions To Warrant Liability AdditionsToWarrantLiability		usd
	SHMP	Warrant Liability Reclass To Equity Upon Exercise WarrantLiabilityReclassToEquityUponExercise		usd
CY2022	SHMP	Warrant Liability Reclass To Equity Upon Exercise WarrantLiabilityReclassToEquityUponExercise		usd
CY2022Q1	SHMP	Fair Value Measurement With Promissory Note FairValueMeasurementWithPromissoryNote		usd
CY2021Q1	SHMP	Fair Value Measurement With Promissory Note FairValueMeasurementWithPromissoryNote		usd
CY2022	SHMP	Fair Value Of Promissory Note Upon Restructuring Agreement FairValueOfPromissoryNoteUponRestructuringAgreement		usd
CY2022	SHMP	Change In Fair Value Of Restructed Notes ChangeInFairValueOfRestructedNotes		usd
CY2022Q1	SHMP	Fair Value Measurement With Promissory Note FairValueMeasurementWithPromissoryNote		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54030
	dei	Entity Registrant Name EntityRegistrantName	NATURALSHRIMP INCORPORATED
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	74-3262176
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5501 LBJ Freeway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 450
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75240
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	791-9474
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	783161589	shares
CY2022Q4	us-gaap	Cash Cash	141864	usd
CY2022Q1	us-gaap	Cash Cash	1734040	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7502	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14385	usd
CY2022Q1	us-gaap	Escrow Deposit EscrowDeposit	1500000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	101929	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	69170	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	490140	usd
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1511546	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	126963	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	868398	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	4829141	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15350443	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14798103	usd
CY2022Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	45730	usd
CY2022Q1	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1087101	usd
CY2022Q4	SHMP	Intangible Assets Nets Excluding Goodwill IntangibleAssetsNetsExcludingGoodwill	6366000	usd
CY2022Q1	SHMP	Intangible Assets Nets Excluding Goodwill IntangibleAssetsNetsExcludingGoodwill	6658500	usd
CY2022Q4	SHMP	Indefinite Lived Intangible Assets IndefiniteLivedIntangibleAssets	9412376	usd
CY2022Q1	SHMP	Indefinite Lived Intangible Assets IndefiniteLivedIntangibleAssets	10222376	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	224266	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	282753	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2022Q1	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16069005	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18271363	usd
CY2022Q4	us-gaap	Assets Assets	32287846	usd
CY2022Q1	us-gaap	Assets Assets	37898607	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3523210	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2802787	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	336102	usd
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	500450	usd
CY2022Q4	SHMP	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	213292	usd
CY2022Q1	SHMP	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	203520	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	299978	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	207418	usd
CY2022Q4	SHMP	Accrued Expenses Related Parties AccruedExpensesRelatedParties	200000	usd
CY2022Q1	SHMP	Accrued Expenses Related Parties AccruedExpensesRelatedParties	200000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	19817	usd
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	20044	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	96000	usd
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	96000	usd
CY2022Q4	SHMP	Restructured August Note Payable RestructuredAugustNotePayable	2219347	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	745412	usd
CY2022Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	495412	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	514391	usd
CY2022Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	296630	usd
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13101000	usd
CY2022Q4	SHMP	Warrant Liability WarrantLiability	892000	usd
CY2022Q1	SHMP	Warrant Liability WarrantLiability	3923000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9059549	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	21846261	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9680000	usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9680000	usd
CY2022Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	2629079	usd
CY2022Q4	us-gaap	Senior Notes SeniorNotes	20223035	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	47604	usd
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	119604	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	231704	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	286253	usd
CY2022Q4	us-gaap	Liabilities Liabilities	29561892	usd
CY2022Q1	us-gaap	Liabilities Liabilities	24881197	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	768561129	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	751322954	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	674831624	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	674644124	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	76894	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	67500	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119464471	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	96701607	usd
CY2022Q4	SHMP	Stock Payable StockPayable	662767	usd
CY2022Q1	SHMP	Stock Payable StockPayable	20132650	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	56250	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-163037985	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150036023	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-42889603	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-33133766	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32287846	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37898607	usd
CY2022Q4	us-gaap	Revenues Revenues	97943	usd
CY2021Q4	us-gaap	Revenues Revenues	16640	usd
	us-gaap	Revenues Revenues	186004	usd
	us-gaap	Revenues Revenues	16640	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1481195	usd
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1527699	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4256819	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5182358	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14212	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20357	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	190855	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	217229	usd
CY2022Q4	us-gaap	Facility Costs FacilityCosts	875194	usd
CY2021Q4	us-gaap	Facility Costs FacilityCosts	398504	usd
	us-gaap	Facility Costs FacilityCosts	1895357	usd
	us-gaap	Facility Costs FacilityCosts	810260	usd
CY2022Q4	us-gaap	Depreciation Depreciation	416377	usd
CY2021Q4	us-gaap	Depreciation Depreciation	218134	usd
	us-gaap	Depreciation Depreciation	1349838	usd
	us-gaap	Depreciation Depreciation	830409	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	367500	usd
CY2021Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	367500	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1102500	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	514000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	3154478	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	2532194	usd
	us-gaap	Operating Expenses OperatingExpenses	8795369	usd
	us-gaap	Operating Expenses OperatingExpenses	7554256	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3056535	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2515554	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8609365	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7537616	usd
CY2022Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	593331	usd
CY2021Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	80991	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1674994	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	228190	usd
CY2022Q4	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	6250	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	9772	usd
CY2022Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	843494	usd
CY2021Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	340000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5019883	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	576364	usd
CY2021Q4	SHMP	Financing Costs FinancingCosts	1393000	usd
	SHMP	Financing Costs FinancingCosts	1502953	usd
CY2022Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	17738000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	811000	usd
CY2022Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1155000	usd
CY2021Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	137000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3031000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	137000	usd
CY2022Q4	SHMP	Change In Fair Value Of Restructured Notes ChangeInFairValueOfRestructuredNotes	1594515	usd
	SHMP	Change In Fair Value Of Restructured Notes ChangeInFairValueOfRestructuredNotes	1594515	usd
	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan	103200	usd
CY2021Q4	SHMP	Gain On Vero Blue Note Settlement GainOnVeroBlueNoteSettlement	500000	usd
	SHMP	Gain On Vero Blue Note Settlement GainOnVeroBlueNoteSettlement	500000	usd
CY2022Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2383088	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2383088	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	29400000	usd
	us-gaap	Legal Fees LegalFees	29400000	usd
CY2022Q4	SHMP	Loss Due To Fire LossDueToFire	-6262	usd
	SHMP	Loss Due To Fire LossDueToFire	-869379	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18232236	usd
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-30850991	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2943455	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31241307	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15175701	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33366545	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11552820	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38778923	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	15175701	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-33366545	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11552820	usd
	us-gaap	Net Income Loss NetIncomeLoss	-38778923	usd
CY2022Q4	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-28048	usd
	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-212048	usd
	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-817376	usd
CY2022Q4	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares	198333	usd
	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares	755333	usd
	SHMP	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares	-5792947	usd
CY2022Q4	us-gaap	Dividends Dividends	60107	usd
	us-gaap	Dividends Dividends	481761	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14889213	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33366545	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13001961	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45389246	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	697586776	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	635536459	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	682750957	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	608191555	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1629304739	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	635536459	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	682750957	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	608191555	shares
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-33133766	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	840000	usd
CY2022Q2	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-42500	usd
CY2022Q2	SHMP	Accretion Of Series E Preferred Shares AccretionOfSeriesEPreferredShares	-278500	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	102227	usd
CY2022Q2	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	24375	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2200176	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-34892794	usd
CY2022Q3	SHMP	Conversion Of Series E Preferred Shares To Common Stock ConversionOfSeriesEPreferredSharesToCommonStock	720000	usd
CY2022Q3	SHMP	Percentage Of Series E Preferred Shares To One Holder PercentageOfSeriesEPreferredSharesToOneHolder	0.10	pure
CY2022Q3	SHMP	Increase In Series E Preferred Shares To One Holder Based On Certain Rights IncreaseInSeriesEPreferredSharesToOneHolderBasedOnCertainRights	-156000	usd
CY2022Q3	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-42500	usd
CY2022Q3	SHMP	Accretion Of Series E Preferred Shares AccretionOfSeriesEPreferredShares	-278500	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	55427	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26000	usd
CY2022Q3	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	24375	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-24528345	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-59183191	usd
CY2022Q4	SHMP	Issuance Of Common Shares Under Financing Agreement IssuanceOfCommonSharesUnderFinancingAgreement	1380000	usd
CY2022Q4	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-28048	usd
CY2022Q4	SHMP	Accretion Of Series E Preferred Shares AccretionOfSeriesEPreferredShares	-198333	usd
CY2022Q4	us-gaap	Dividends Preferred Stock DividendsPreferredStock	60107	usd
CY2022Q4	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	24375	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	15175701	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-42889603	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3070969	usd
CY2021Q2	SHMP	Issuance Of Common Share Upon Conversion Amount IssuanceOfCommonShareUponConversionAmount	421486	usd
CY2021Q2	SHMP	Exchange Of Series D Ps To Series E Ps ExchangeOfSeriesDPsToSeriesEPs	-3258189	usd
CY2021Q2	SHMP	Sale Of Common Shares And Warrants For Cash Less Offering Costs And Commitment Shares Amount SaleOfCommonSharesAndWarrantsForCashLessOfferingCostsAndCommitmentSharesAmount	17277123	usd
CY2021Q2	SHMP	Exercise Of Warrants Related To The Sale Of Common Shares Amount ExerciseOfWarrantsRelatedToTheSaleOfCommonSharesAmount	11000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3269505	usd
CY2021Q2	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-817376	usd
CY2021Q2	SHMP	Redemption Of Series D Preferred Shares RedemptionOfSeriesDPreferredShares	-2534758	usd
CY2021Q2	SHMP	Common Shares To Be Issued For Acquisition Of Noncontrolling Interest Subsidiarys Remaining Equity CommonSharesToBeIssuedForAcquisitionOfNoncontrollingInterestSubsidiarysRemainingEquity	-1000000	usd
CY2021Q2	SHMP	Common Shares To Be Issued For Patent Acquisition CommonSharesToBeIssuedForPatentAcquisition	5000000	usd
CY2021Q2	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	73651	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2562743	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18950668	usd
CY2021Q3	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-1341948	usd
CY2021Q3	SHMP	Revision Of Dividends Payable On Series B Preferred Shares RevisionOfDividendsPayableOnSeriesBPreferredShares	-182639	usd
CY2021Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	177586	usd
CY2021Q3	SHMP	Common Shares To Be Issued For Technical And Equipment Rights Agreement CommonSharesToBeIssuedForTechnicalAndEquipmentRightsAgreement	4762376	usd
CY2021Q3	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	49275	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2849635	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19210511	usd
CY2021Q4	SHMP	Conversion Of Series B Ps To Common Stock Amount ConversionOfSeriesBPsToCommonStockAmount	-334	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2880000	usd
CY2021Q4	SHMP	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-831543	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	169714	usd
CY2021Q4	SHMP	Accretion Of Series E Preferred Shares AccretionOfSeriesEPreferredShares	-80167	usd
CY2021Q4	us-gaap	Dividends Preferred Stock DividendsPreferredStock	112577	usd
CY2021Q4	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	49275	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	158328	usd
CY2021Q4	SHMP	Common Stock Vested To Employees CommonStockVestedToEmployees	68304	usd
CY2021Q4	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	-2935000	usd
CY2021Q4	SHMP	Common Stock To Be Issued For Legal Settlement To Nsh Shareholders CommonStockToBeIssuedForLegalSettlementToNSHShareholders	29388000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-33366545	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-33366545	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14597966	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11552820	usd
	us-gaap	Net Income Loss NetIncomeLoss	-38778923	usd
	SHMP	Depreciation Expense DepreciationExpense	1349838	usd
	SHMP	Depreciation Expense DepreciationExpense	586409	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1102500	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	514000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5019883	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	576364	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	811000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3031000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	137000	usd
	SHMP	Change In Fair Value Of Promissory Notes ChangeInFairValueOfPromissoryNotes	1594515	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1502953	usd
	SHMP	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	1883089	usd
	SHMP	Loss Due To Fire LossDueToFire	-869379	usd
	SHMP	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan	103200	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	500000	usd
	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	29388000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	99124	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	398831	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6883	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32759	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28128	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1021406	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	321162	usd
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	126963	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	724360	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5637796	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	92560	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-101896	usd
	SHMP	Increase Decrease In Accrued Expenses Related Parties IncreaseDecreaseInAccruedExpensesRelatedParties	200000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1662647	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-49482	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	9772	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	16000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3884764	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12201031	usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	2430186	usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	2116124	usd
	SHMP	Cash Received For Fire Damage To Fixed Assets CashReceivedForFireDamageToFixedAssets	-700000	usd
	SHMP	Cash Paid For Patent Acquisition CashPaidForPatentAcquisition	2000000	usd
	SHMP	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci	1000000	usd
	SHMP	Cash Paid For License Agreement CashPaidForLicenseAgreement	2350000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	433389	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1730186	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7899513	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	214852	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	72000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	72000	usd
	SHMP	Repayments Of Notes Payable Related Party RepaymentsOfNotesPayableRelatedParty	655750	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	227	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	553577	usd
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	17277123	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1380000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1465000	usd
	SHMP	Proceeds From Promissory Note Related Parties ProceedsFromPromissoryNoteRelatedParties	250000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	8905000	usd
	SHMP	Proceeds From Convertible Debentures Receipt ProceedsFromConvertibleDebenturesReceipt	1500000	usd
	SHMP	Escrow Account In Relation To The Proceeds From Convertible Debenture EscrowAccountInRelationToTheProceedsFromConvertibleDebenture	-500000	usd
	SHMP	Escrow Account In Relation To The Proceeds From Convertible Debenture EscrowAccountInRelationToTheProceedsFromConvertibleDebenture	5000000	usd
	SHMP	Payments On Convertible Debentures PaymentsOnConvertibleDebentures	421486	usd
	SHMP	Payments On Notes Payable PaymentsOnNotesPayable	4500000	usd
	SHMP	Proceeds From Sale Of Series E Ps ProceedsFromSaleOfSeriesEPs	1348000	usd
	SHMP	Redemption Of Series D Ps RedemptionOfSeriesDPs	-3513504	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	11000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4022773	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22609954	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1592176	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2509411	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1734040	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155795	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	141864	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2665206	usd
	us-gaap	Interest Paid Net InterestPaidNet	1829570	usd
	us-gaap	Interest Paid Net InterestPaidNet	212190	usd
	SHMP	Construction In Process Transferred To Fixed Assets ConstructionInProcessTransferredToFixedAssets	1041371	usd
	SHMP	Shares Issued Upon Conversion Of Convertible Debentures SharesIssuedUponConversionOfConvertibleDebentures	421486	usd
	SHMP	Shares Issued Upon Conversion Of Preferred Stock SharesIssuedUponConversionOfPreferredStock	1560000	usd
	SHMP	Cancellation Of Right Of Use Asset And Lease Liability CancellationOfRightOfUseAssetAndLeaseLiability	275400	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	4762376	shares
	SHMP	Shares Issued As Consideration For Patent Acquisition SharesIssuedAsConsiderationForPatentAcquisition	5000000	usd
	SHMP	Shares Issued As Consideration For Acquisition Of Remaining Nci SharesIssuedAsConsiderationForAcquisitionOfRemainingNci	2000000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_z1Xslr4d0R46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82C_ziCAYOpqaju4">NATURE OF THE ORGANIZATION AND BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature of the Business</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NaturalShrimp Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a biotechnology company and has developed a proprietary technology that allows it to grow Pacific White shrimp (Lit Penaeus, formerly Penaeus vannamei) in an ecologically controlled, high-density, low-cost environment, and in fully contained and independent production facilities. The Company’s system uses technology which allows it to produce a naturally grown shrimp “crop” weekly and accomplishes this without the use of antibiotics or toxic chemicals. The Company has developed several proprietary technology assets, including a knowledge base that allows it to produce commercial quantities of shrimp in a closed system with a computer monitoring system that automates, monitors and maintains proper levels of oxygen, salinity and temperature for optimal shrimp production. The Company’s production facilities are located in La Coste, Texas and Webster City, Iowa.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 17, 2020, the Company closed on an Asset Purchase Agreement (“APA”) between VeroBlue Farms USA, Inc., a Nevada corporation (“VBF”), VBF Transport, Inc., a Delaware corporation (“Transport”), and Iowa’s First, Inc., an Iowa corporation (“Iowa’s First”) (each a “Seller” and collectively, “Sellers”). Transport and Iowa’s First were wholly-owned subsidiaries of VBF. The agreement called for the Company to purchase all of the tangible assets of VBF, the motor vehicles of Transport and the real property (together with all plants, buildings, structures, fixtures, fittings, systems and other improvements located on such real property) of Iowa’s First. The facility was originally designed as an aquaculture facility, with the company having production issues. The Company began a modification process to convert the plant to produce shrimp, which will allow them to scale faster without having to build new facilities. The three Iowa facilities contain the tanks and infrastructure that will be used to support the production of shrimp with the incorporation of the Company’s patented EC platform technology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 19, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with F&T Water Solutions, LLC (“F&T”), for F&T’s owned shares of Natural Aquatic Systems, Inc. (“NAS”). Prior to entering into the SPA, the Company owned fifty-one percent (<span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210518__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SecuritiesPurchaseAgreementMember_zL10TiPxkuZ6" title="Ownership percentage">51</span>%) and F&T owned forty-nine percent (<span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210518__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FAndTWaterSolutionsLLCMember_zPsfCB5hXh75" title="Ownership percentage">49</span>%) of the issued and outstanding shares of common stock of NAS. After the SPA, NAS is a <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210519__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NaturalAquaticSystemsIncMember_zEJtYmMPpjXa" title="Ownership percentage">100</span>% owned subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has three wholly-owned subsidiaries including NaturalShrimp USA Corporation, NaturalShrimp Global, Inc. and NAS.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the nine months ended December 31, 2022, the Company had a net loss from operations of approximately $<span id="xdx_90F_eus-gaap--OperatingIncomeLoss_iN_pn3p0_di_c20220401__20221231_ztmYLPJLYlnk" title="Net loss from operation">8,609,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. At December 31, 2022, the Company had an accumulated deficit of approximately $<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3p0_di_c20221231_zvaiz7Gk60Wi" title="Accumulated deficit">163,038,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and a working capital deficit of approximately $<span id="xdx_90A_ecustom--WorkingCapitalDeficit_iNI_di_c20221231_zvPnBoOzW593" title="Working capital deficit">8,191,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. These factors raise substantial doubt about the Company’s ability to continue as a going concern, within one year from the issuance date of this filing. The Company’s ability to continue as a going concern is dependent on its ability to raise the required additional capital or debt financing to meet short and long-term operating requirements. During the nine months ended December 31, 2022, the Company received the $<span id="xdx_90F_ecustom--ProceedsFromConvertibleDebenturesReceipt_pp0p0_c20220401__20221231_zbdAp7yjyFt9" title="Proceeds from convertible debentures">1,500,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">remaining escrow amount related to the proceeds from the issuance of a convertible debenture in December 2021, as well as $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20220801__20220831_znr4XlMGxVOi" title="Proceeds from convertible stock">1,465,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from the issuance of a convertible debenture in August 2022, per the restructuring agreement and $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfDebt_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zMsMwlblyvGe" title="Issuance of debt">250,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in a loan agreement with related parties. Additionally, the Company entered into a Purchase Agreement with GHS Investments LLC (“GHS”) under which the Company may require GHS to purchase a maximum of up to <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221104__us-gaap--TypeOfArrangementAxis__custom--GHSPurchaseAgreementMember_zmEZnJ9nFlge" title="Warrant to purchase shares">64,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock (“GHS Purchase Shares”) based on a total aggregate purchase price of up to $<span id="xdx_903_eus-gaap--PaymentsForRepurchaseOfWarrants_c20221103__20221104__us-gaap--TypeOfArrangementAxis__custom--GHSPurchaseAgreementMember_zp6QRc1olan2" title="Purchase price for warrants">5,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">over a one-year term that ends on November 4, 2023 (see Note 11). During the three months ended December 31, 2022, the Company received a net amount of approximately $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20221001__20221231_zYjQqe46GuJ2" title="Sale of stock consideration">1,380,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for the sale of <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20221001__20221231_zIn5Q6WnL6id" title="Sale of stock number of shares">17,175,675 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. Subsequent to the period end, the Company has received another $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230101__20230214__us-gaap--TypeOfArrangementAxis__custom--GHSPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zlA0qDXUy5tc" title="Sale of stock consideration received on transaction">878,365 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from GHS for the sale of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230101__20230214__us-gaap--TypeOfArrangementAxis__custom--GHSPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwbDNIRWe2Sd" title="Sale of stock consideration">14,880,460 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. Management believes that private placements of equity capital will be needed to fund the Company’s long-term operating requirements. The Company may also encounter business endeavors that require significant cash commitments or unanticipated problems or expenses that could result in a requirement for additional cash. If the Company raises additional funds through the issuance of equity, the percentage ownership of its current shareholders could be reduced, and such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict our operations. The Company continues to pursue external financing alternatives to improve its working capital position. If the Company is unable to obtain the necessary capital, the Company may be unable to develop its facilities and enter in production.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8609000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-163038000	usd
CY2022Q4	SHMP	Working Capital Deficit WorkingCapitalDeficit	-8191000	usd
	SHMP	Proceeds From Convertible Debentures Receipt ProceedsFromConvertibleDebenturesReceipt	1500000	usd
CY2022Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1465000	usd
CY2022Q4	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	1380000	usd
CY2022Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	17175675	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zrmm4Ol2N0Kj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zw8eghaG29ce">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18573116	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18506429	shares
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	13101000	usd
	SHMP	Gain On Extinguishment Of Note GainOnExtinguishmentOfNote	-12290000	usd
CY2022	SHMP	Additions To Derivative Liabilities AdditionsToDerivativeLiabilities	12985000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-811000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	116000	usd
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	13101000	usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3923000	usd
CY2022	SHMP	Additions To Warrant Liability AdditionsToWarrantLiability	5910000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3031000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1987000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	892000	usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3923000	usd
	SHMP	Fair Value Of Promissory Note Upon Restructuring Agreement FairValueOfPromissoryNoteUponRestructuringAgreement	20847867	usd
	SHMP	Change In Fair Value Of Restructed Notes ChangeInFairValueOfRestructedNotes	-1594515	usd
CY2022Q4	SHMP	Fair Value Measurement With Promissory Note FairValueMeasurementWithPromissoryNote	22442382	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zZSamugwDbe6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zoUJTDY7Say4">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances at two financial institutions. Accounts at this institution are insured by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20221231_z7aN5mAZRtTc" title="Cash, FDIC insured amount">250,000</span>. <span style="background-color: white">As of </span>December 31, 2022, the Company’s cash balance did not exceed FDIC coverage. As of <span style="background-color: white">March 31, 2022, the Company’s cash balance exceeded FDIC coverage. </span>The Company has not experienced any losses in such accounts and periodically evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Land Land	324293	usd
CY2022Q1	us-gaap	Land Land	324293	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5439365	usd
CY2022Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5611723	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	12210036	usd
CY2022Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10524343	usd
CY2022Q4	SHMP	Automobiles Gross AutomobilesGross	307227	usd
CY2022Q1	SHMP	Automobiles Gross AutomobilesGross	247356	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18280921	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16707715	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2930478	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1909612	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15350443	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14798103	usd
CY2022Q4	us-gaap	Depreciation Depreciation	416000	usd
CY2021Q4	us-gaap	Depreciation Depreciation	218000	usd
	us-gaap	Depreciation Depreciation	1350000	usd
	us-gaap	Depreciation Depreciation	830000	usd
CY2022Q3	us-gaap	Area Of Land AreaOfLand	8000	sqft
CY2022Q3	us-gaap	Insurance Recoveries InsuranceRecoveries	700000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1764000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	325000	usd
CY2022Q3	us-gaap	Insurance Recoveries InsuranceRecoveries	700000	usd
	SHMP	Description For Uplisted Term And Trigger Events DescriptionForUplistedTermAndTriggerEvents	In conjunction with the Merger Agreement, entered into on October 24, 2022, with Yotta Acquisition Corporation (Note 10), on November 4, 2022, the Company entered into a Restructuring Agreement for an Amended and Restated Secured Promissory Note (the “August Note”), through which the August Note was amended and restated in its entirety. The Restructuring Agreement included key modifications, in which i) the Uplist terms were removed, ii) in the event that the Closing of the Merger does not occur on or before December 31, 2022, the then-current Outstanding Balance will be increased by 2% and shall increase by 2% every 30 days thereafter until the Closing or termination of the Merger Agreement, and iii) the outstanding balance of the Convertible Note may be increased by 5% to 15% upon the occurrence of an event of default or failure to obtain the Lender’s consent or notify the Lender for certain major equity related transactions (“Trigger Events”). The Merger has not yet closed, and therefore the 2% of the outstanding balance was increased as of December 31, 202
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	35000	usd
CY2022Q4	SHMP	Increase In Outstanding Balance Percentage IncreaseInOutstandingBalancePercentage	0.10	pure
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	99000	usd
	SHMP	Percentage Of Series E Preferred Shares To One Holder PercentageOfSeriesEPreferredSharesToOneHolder	0.10	pure
	SHMP	Increase In Series E Preferred Shares To One Holder Based On Certain Rights Shares IncreaseInSeriesEPreferredSharesToOneHolderBasedOnCertainRightsShares	130	shares
	SHMP	Increase In Series E Preferred Shares To One Holder Based On Certain Rights IncreaseInSeriesEPreferredSharesToOneHolderBasedOnCertainRights	156000	usd
	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.15	pure
CY2022Q4	us-gaap	Debt Conversion Description DebtConversionDescription	the stated value of $1,200 per share plus any unpaid dividends, multiplied by 1.25, divided by (ii) 80% of the average volume weighted average price of the Company’s common stock during the five trading day period immediately prior to the Closing Date.
CY2022Q4	SHMP	Warrant Liability WarrantLiability	892000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3031000	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	119000	usd
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	119000	usd
CY2016Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.02	pure
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	161000	usd
CY2022Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	146000	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	290000	usd
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
CY2021Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
	us-gaap	Operating Lease Payments OperatingLeasePayments	1727	usd
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
CY2021Q2	us-gaap	Deposits Deposits	52362	usd
CY2021Q2	us-gaap	Security Deposit SecurityDeposit	17454	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	316000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	300	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure

Files In Submission

Name	View Source	Status
0001493152-23-005319-index-headers.html	Edgar Link	pending
0001493152-23-005319-index.html	Edgar Link	pending
0001493152-23-005319.txt	Edgar Link	pending
0001493152-23-005319-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shmp-20221231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
shmp-20221231_cal.xml	Edgar Link	unprocessable
shmp-20221231_def.xml	Edgar Link	unprocessable
shmp-20221231_lab.xml	Edgar Link	unprocessable
shmp-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHMP
NaturalShrimp Inc Stock $shmp

2023 Q1 Form 10-Q Financial Statement

#000149315223005319 Filed on February 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP NaturalShrimp Inc Stock $shmp

2023 Q1 Form 10-Q Financial Statement

#000149315223005319 Filed on February 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP
NaturalShrimp Inc Stock $shmp